FDA Dep. Director Says AI/ML Data Collection Needs to Avoid Bias

Applications that use AI and machine learning (ML) have a unique dependence on data, said the FDA’s Digital Health Center of Excellence Acting Deputy Director MiRa Jacobs at Tuesday’s open forum held by the Alliance for a Stronger FDA.
Source: Drug Industry Daily

Leave a Reply